Foamix/PDUFA
Hi guys,
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology
- An NDA for FMX101 to treat acne vulgaris was filed with the FDA.
- A PDUFA date has been established for October 20, 2019.
Long:- LMT 1- 3.15$ (20 % of the planned investment amount)
- LMT 2- 2.89$ (40 % of the planned investment amount)
- LMT 3- 2.78$ (40 % of the planned investment amount)
TP:7$
Comments and likes are greatly appreciated.
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.
- LMT 3- 2.78$ (40 % of the planned investment amount)
- LMT 2- 2.89$ (40 % of the planned investment amount)
- LMT 1- 3.15$ (20 % of the planned investment amount)
- A PDUFA date has been established for October 20, 2019.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.